DD216011A5 - Verfahren zur herstellung eines guanidinabkoemmlings - Google Patents

Verfahren zur herstellung eines guanidinabkoemmlings Download PDF

Info

Publication number
DD216011A5
DD216011A5 DD83254562A DD25456283A DD216011A5 DD 216011 A5 DD216011 A5 DD 216011A5 DD 83254562 A DD83254562 A DD 83254562A DD 25456283 A DD25456283 A DD 25456283A DD 216011 A5 DD216011 A5 DD 216011A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
alkyl
ring
hydrogen
nitrogen
Prior art date
Application number
DD83254562A
Other languages
German (de)
English (en)
Inventor
Neil J Hales
Derrick M Mant
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of DD216011A5 publication Critical patent/DD216011A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
DD83254562A 1982-09-07 1983-09-06 Verfahren zur herstellung eines guanidinabkoemmlings DD216011A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8225509 1982-09-07

Publications (1)

Publication Number Publication Date
DD216011A5 true DD216011A5 (de) 1984-11-28

Family

ID=10532749

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83254562A DD216011A5 (de) 1982-09-07 1983-09-06 Verfahren zur herstellung eines guanidinabkoemmlings

Country Status (13)

Country Link
EP (1) EP0105590B1 (no)
JP (1) JPS59134781A (no)
AT (1) ATE24492T1 (no)
DD (1) DD216011A5 (no)
DE (1) DE3368612D1 (no)
DK (1) DK367783A (no)
ES (2) ES525445A0 (no)
FI (1) FI833161A (no)
GB (1) GB8316779D0 (no)
GR (1) GR81302B (no)
NO (1) NO833179L (no)
PT (1) PT77263B (no)
SU (1) SU1303027A3 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8401751D0 (en) * 1984-01-24 1984-02-29 Ici Plc Guanidine derivatives
JP4746528B2 (ja) * 2006-12-06 2011-08-10 株式会社マスカワ ガスケット
JP2011099631A (ja) 2009-11-06 2011-05-19 Denso Corp 熱交換器
MY165612A (en) 2010-11-05 2018-04-18 Senomyx Inc Compounds useful as modulators of trpm8
BR112018006471B1 (pt) 2015-10-01 2024-02-27 Senomyx, Inc Composto, composição, método de modular o membro de melastina do canal potencial do receptor transitório 8 (trpm8), método de modular a sensação de resfrescância de uma composição e método de induzir uma sensação de refrescância em um ser humano ou animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
IN158869B (no) * 1981-03-18 1987-02-07 Ici Plc

Also Published As

Publication number Publication date
ES541830A0 (es) 1985-12-01
ES8507101A1 (es) 1985-08-16
ATE24492T1 (de) 1987-01-15
DK367783D0 (da) 1983-08-12
EP0105590B1 (en) 1986-12-30
NO833179L (no) 1984-03-08
PT77263A (en) 1983-09-01
SU1303027A3 (ru) 1987-04-07
JPS59134781A (ja) 1984-08-02
EP0105590A1 (en) 1984-04-18
FI833161A (fi) 1984-03-08
ES525445A0 (es) 1985-08-16
FI833161A0 (fi) 1983-09-05
GR81302B (no) 1984-12-11
PT77263B (en) 1986-02-04
ES8602624A1 (es) 1985-12-01
DE3368612D1 (en) 1987-02-05
GB8316779D0 (en) 1983-07-27
DK367783A (da) 1984-03-08

Similar Documents

Publication Publication Date Title
DE3788145T2 (de) Piperidinderivate, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung.
DE69222595T2 (de) Pyrazolopyrimidone als Wirkstoffe gegen Angina
DE69212870T2 (de) 4-Aryl-thiazole oder imidazolederivate
DE69010015T2 (de) 2-Aminopyrimidinon-Derivate.
CH651300A5 (de) Heterocyclisch substituierte aminopropennitrile.
EP0772593B1 (de) Pyridylthioverbindungen zur bekämpfung von helicobacter-bakterien
DE69127976T2 (de) Tropolonderivate und pharmazeutische zubereitungen davon zur vorbeugung und behandlung von ischämischen krankheiten
EP0047328B1 (de) 1H- und 2H-Indazolderivate und diese enthaltendes Arzneimittel
DD216011A5 (de) Verfahren zur herstellung eines guanidinabkoemmlings
DD202552A5 (de) Heterocyclische derivate
DE3615180C2 (de) Disubstituierte 1,4-Piperazinylderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE3509333A1 (de) Substituierte benzimidazolderivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
DE2052692A1 (de) Isothioharnstoffverbmdungen, ihre Salze mit Sauren, Verfahren zu ihrer Her stellung und ihre Verwendung zur Her stellung von Arzneimitteln
DE3781703T2 (de) 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel.
DE69216143T2 (de) Prozess und 2-(Cyanoimino)-Quinazlin-Zwischenprodukte zur Herstellung von 6,7-Di(Chloro)-1,5-Di(Hydro)-Imidazo-[2,1-b]Quinazolin-2[3H]-on sowie Prozess zur Darstellung der 2-(Cyanoimino)Quinazolin
EP0010652B1 (de) Neue 4-Chloroxazole, Verfahren zu deren Herstellung und deren Verwendung in photoleitenden Schichten in der Elektrophotographie und als optische Aufheller
DD206994A5 (de) Verfahren zur herstellung von pyridinderivaten
DD144916A5 (de) Verfahren zur herstellung von pyrimidinverbindungen und ihren salzen
DE68917049T2 (de) Furylthiazol-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
DE3814057A1 (de) 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69018996T2 (de) Imidazol-derivate und ihre verwendung als acyl coenyzm-a inhibitoren.
DE3879243T2 (de) Pyrazolderivate, verfahren zu deren herstellung und herbizide, welche diese derivate als wirksubstanz enthalten.
DE3878578T2 (de) Benzimidazol-derivate und verfahren zu ihrer herstellung.
DE3826855A1 (de) 4,5-dihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung
DD237509A5 (de) Verfahren zur herstellung von 2-(1h)-chinolonen